Details for New Drug Application (NDA): 204239
✉ Email this page to a colleague
The generic ingredient in LINEZOLID is linezolid. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the linezolid profile page.
Summary for 204239
Tradename: | LINEZOLID |
Applicant: | Hetero Labs Ltd V |
Ingredient: | linezolid |
Patents: | 0 |
Suppliers and Packaging for NDA: 204239
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LINEZOLID | linezolid | TABLET;ORAL | 204239 | ANDA | Camber Pharmaceuticals, Inc. | 31722-749 | 31722-749-01 | 100 TABLET, FILM COATED in 1 BOTTLE (31722-749-01) |
LINEZOLID | linezolid | TABLET;ORAL | 204239 | ANDA | Camber Pharmaceuticals, Inc. | 31722-749 | 31722-749-20 | 20 TABLET, FILM COATED in 1 BOTTLE (31722-749-20) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
Approval Date: | Dec 21, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription